A novel immune regulatory peptide, PEPITEM (peptide inhibitor of trans-endothelial migration), controls T-cell trafficking during inflammation, a tonic inhibitory pathway that is lost in Type 1 diabetes

Research output: Contribution to journalArticle

Authors

Details

Original languageEnglish
Pages (from-to)46-46
Number of pages1
JournalDiabetic Medicine
Volume31
Issue numberSupp 1
Publication statusPublished - Mar 2014